臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"szu chun"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 25 (1 Page(s) Totally)
1
View [10|25|50] records per page

Institution	Date	Title	Author
國立成功大學	2023-11-2	Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection	Cheng;Jordan;Swarup;Neeti;Li;Feng;Kordi;Misagh;Lin;Chien-Chung;Yang;Szu-Chun;Huang;Wei-Lun;Aziz;Mohammad;Kim;Yong;Chia;David;Yeh;Yu-Min;Wei;Fang;Zheng;David;Zhang;Liying;Pellegrini;Matteo;Su;Wu-Chou;Wong;David, T. W.
國立成功大學	2023-08-16	Estimation of disability free life expectancy in non small cell lung cancer based on real world data	Lin;Shin-Mao;Yang;Szu-Chun;Wu;Tzu-I;Wang;Jung-Der;Liu;Li-Fan
國立成功大學	2023-03-9	Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs	Chu;Chang-Yao;Lin;Chien-Yu;Lin;Chien-Chung;Li;Chien-Feng;Wu;Shang-Yin;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Su;Wu-Chou
國立成功大學	2023-03	Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre	Wu;Chi-Hao;Ku;Elizabeth, Li-Jung;Lin;Chien-Yu;Chung;Ta-Jung;Liu;Hui-Ju;Chao;Ting-Hsing;Yang;Szu-Chun
國立成功大學	2023--AUG	Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer	Yang;Szu-Chun;Lai;Wu-Wei;Wu;Tzu-I;Hwang;Jing-Shiang;Wang;Jung-Der;Wang;Fuhmei
國立成功大學	2022-11	PM2.5 exposure and risk of lung adenocarcinoma in women of Taiwan: A case-control study with density sampling	Yang;Szu-Chun;Lin;Fang-Yu;Wu;Tzu-;I;Wu;Chih-Da;Wang;Jung-Der
國立成功大學	2022-11	Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio	Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-05-21	Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program	Kuo;Chin-Wei;Chen;Chuan-Yu;Wu;Chih-Hsing;Chen;Chang-Wen;Guo;Fei-Ran;Yang;Szu-Chun
國立成功大學	2022-05-20	Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naive Metastatic Lung Adenocarcinoma	Yang;Szu-Chun;Lin;Chien-Chung;Chen;Yi-Lin;Su;Wu-Chou
國立成功大學	2022-03-14	Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study	Kuo;Chin-Wei;Yang;Szu-Chun;Shih;Yu-Fen;Liao;Xin-Min;Lin;Sheng-Hsiang
國立成功大學	2022-02-28	The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy	Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-01	Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors	Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-12	QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon	Lai;Wu-Wei;Chung;Chia-Hua;Lin;Chia-Ni;Yang;Szu-Chun;Hwang;Jing-Shiang;Wang;Jung-Der
國立成功大學	2021-09	EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis	Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-06-9	Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data	Yang;Szu-Chun;Wang;Jung-Der;Wang;Shi-Yi
國立成功大學	2021-04	Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan	Yang;Szu-Chun;Lai;Ching-Han;Kuo;Chin-Wei;Lin;Chien-Chung;Lai;Wu-Wei;Wang;Jung-Der
國立成功大學	2020-12	Indigenous recurrent disseminated histoplasmosis in Taiwan	Kuo;Hung-I;Liao;Xin-Min;Yang;Szu-Chun;Lee;Jen-Chieh;Chang;Kung-Chao;Cia;Cong-Tat
國立成功大學	2020-04-8	Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan	Yang;Szu-Chun;Lai;Wu-Wei;Hsu;Jason, C.;Su;Wu-Chou;Wang;Jung-Der
國立成功大學	2019-11	Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up	Yang;Szu-Chun;Kuo;Chin-Wei;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou;Chang;Sheng-Mao;Wang;Jung-Der
國立成功大學	2019-10	Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment	Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2019-06	Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study	Hsu;Jason, C.;Wei;Chen-Fang;Yang;Szu-Chun
國立成功大學	2018-09-25	Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer	Su;Po-Lan;Wu;Yi-Lin;Chang;Wei-Yuan;Ho;Chung-Liang;Tseng;Yau-Lin;Lai;Wu-Wei;Su;Wu-Chou;Lin;Chien-Chung;Yang;Szu-Chun
國立成功大學	2018-02-5	Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer	Yang;Szu-Chun;Lin;Chien-Chung;Lai;Wu-Wei;Chang;Sheng-Mao;Hwang;Jing-Shiang;Su;Wu-Chou;Wang;Jung-Der
國立成功大學	2018-02-15	The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis	Chang;Wei-Yuan;Wu;Yi-Lin;Su;Po-Lan;Yang;Szu-Chun;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2017-03-14	Liquid biopsy genotyping in lung cancer: ready for clinical utility?	Huang;Wei-Lun;Chen;Yi-Lin;Yang;Szu-Chun;Ho;Chung-Liang;Wei;Fang;Wong;David, T.;Su;Wu-Chou;Lin;Chien-Chung

Showing items 1-25 of 25 (1 Page(s) Totally)
1
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2816755
	???header.visitor??? : 27593232 ???header.onlineuser??? : 500 ???header.sponsordeclaration???